Wed, Sep 17, 2014, 10:46 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • redsavina2001 redsavina2001 Oct 13, 2012 3:18 PM Flag

    FEV-1

    Dr. Steven Rowe the first clinician to inject VX-770 for research in this country says:

    ".....Dr. Steven Rowe of the University of Alabama, Birmingham and also an investigator in the VX-809/Kalydeco study, had a similar view:

    "It's exciting to see the combination treatment come to fruition. It's a phase II design and we've been fooled before but this looks pretty convincing."

    Rowe on what a 6% improvement in lung function means to a CF patient:

    "FEV1 is a speedometer for CF patients. It's what they check every time they come to clinic and so, even small changes mean a fair amount to patients. These results compare favorably to many other drugs that have been approved and widely used for CF, so I think people would be excited about it."

 
VRTX
94.50+0.64(+0.68%)Sep 17 4:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.